Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample
Victoria Amalie Nygart, Lis Marie Pommerencke, Eline Haijen, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 932-942
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Canalization and plasticity in psychopathology
Robin Carhart‐Harris, Shamil Chandaria, David Erritzøe, et al.
Neuropharmacology (2022) Vol. 226, pp. 109398-109398
Open Access | Times Cited: 64
Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice
Jacob S. Aday, Zachary Skiles, Noa Eaton, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 1, pp. 27-37
Closed Access | Times Cited: 38
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice
Daniel Ryskamp Rijsketic, Austen B. Casey, Daniel A. N. Barbosa, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 12, pp. 1798-1807
Open Access | Times Cited: 28
Effects of DMT on mental health outcomes in healthy volunteers
Christopher Timmermann, Richard J. Zeifman, David Erritzøe, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom
Ludwig Honk, Cecilia U. D. Stenfors, Simon B. Goldberg, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 194-201
Closed Access | Times Cited: 7
Eating disorder patients with and without PTSD treated in residential care: discharge and 6-month follow-up results
Timothy D. Brewerton, Ismael Gavidia, Giulia Suro, et al.
Journal of Eating Disorders (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 18
The integrated treatment of eating disorders, posttraumatic stress disorder, and psychiatric comorbidity: a commentary on the evolution of principles and guidelines
Timothy D. Brewerton
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 16
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access
A prospective ecological momentary assessment study of an ayahuasca retreat: exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life
Sharon R. Sznitman, Yoel A. Behar, Sheila Daniela Dicker‐Oren, et al.
Psychopharmacology (2025)
Open Access
Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111300-111300
Closed Access
The intensity of the psychedelic experience is reliably associated with clinical improvements: a systematic review and meta-analysis
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106086-106086
Closed Access
Self-treatment with psychedelic substances for health and wellbeing in Aotearoa New Zealand: an exploratory descriptive study
Chris Arnison, Richard Egan, John H. Shaver
Kōtuitui New Zealand Journal of Social Sciences Online (2025), pp. 1-22
Open Access
Naturalistic psychedelic experiences and gender-based self-acceptance in transgender and gender-expansive people
Skylar J. Gaughan, Angie R. Wootton, David S. Krantz, et al.
International Journal of Transgender Health (2025), pp. 1-16
Open Access
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts
Ar Wilson-Poe, Ka Hoffman, Kellie Pertl, et al.
Journal of Psychoactive Drugs (2024), pp. 1-8
Closed Access | Times Cited: 4
Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use
Nicolas G. Glynos, Anne Baker, Jacob S. Aday, et al.
British Journal of Pain (2025)
Closed Access
Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey
Nicolas G. Glynos, Jacob S. Aday, Daniel J. Kruger, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Focusing on the negative: cases of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
(2023)
Open Access | Times Cited: 8
The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics
Paweł Orłowski, Justyna Hobot, Anastasia Ruban, et al.
Journal of Psychopharmacology (2023) Vol. 38, Iss. 1, pp. 68-79
Closed Access | Times Cited: 8
Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences
Fiona Low, Mitch Earleywine
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 3, pp. 316-323
Closed Access | Times Cited: 7
EMBARK Psychedelic Therapy for Depression
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
Rethinking the role of TRKB in the action of antidepressants and psychedelics
Cecilia A. Brunello, Cecilia Cannarozzo, Eero Ċastrén
Trends in Neurosciences (2024)
Open Access | Times Cited: 2
Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. participants of Color: A longitudinal online survey study
Grant Jones, Matthew X. Lowe, Sandeep M. Nayak, et al.
Journal of Affective Disorders (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top